Document is current
Any future updates will be listed below
-
Authors
Rosenberg, Julie B. https://orcid.org/0000-0002-1320-3582
Sevelsted, Astrid
Jepsen, Jens Richardt M.
Vinding, Rebecca
Mohammadzadeh, Parisa
Hernández Lorca, María https://orcid.org/0000-0002-0923-7173
Horner, David
Sørensen, Mikkel E. https://orcid.org/0009-0009-8829-8545
Fagerlund, Birgitte https://orcid.org/0000-0003-4547-2944
Bilenberg, Niels https://orcid.org/0000-0002-5838-556X
Pantelis, Christos https://orcid.org/0000-0002-9565-0238
Glenthøj, Birte Y. https://orcid.org/0000-0003-3056-7262
Chawes, Bo
Stokholm, Jakob
Ebdrup, Bjørn H. https://orcid.org/0000-0002-2590-5055
Bønnelykke, Klaus
-
Funding
Funding for this research was provided by:
Lundbeckfonden (R269-2017-5)
Lundbeckfonden (R269-2017-5)
Lundbeckfonden (R269-2017-5)
Lundbeckfonden (R269-2017-5)
Lundbeckfonden (R269-2017-5)
EC | Horizon 2020 Framework Programme (946228)
- License Information
-
More Information
Article History
Received: 17 February 2025
Revised: 7 April 2026
Accepted: 12 June 2026
First Online: 2 July 2026
Competing interests
: The authors affirm that they have no financial, personal, or professional conflicts of interest that could have influenced the research presented in this manuscript. BHE is part of the Advisory Board of Boehringer Ingelheim, Lundbeck Pharma, and Orion Pharma; and has received lecture fees from Boehringer Ingelheim, Otsuka Pharma Scandinavia AB, and Lundbeck Pharma. The funding agencies did not have any role in design and conduct of the study; collection, management, and interpretation of the data; or preparation, review, or approval of the manuscript.
: All methods were performed in accordance with the relevant guidelines and regulations. The study was approved by the Local Ethics Committee (H-B-2008-093), and the Danish Data Protection Agency (2015-41-3696). All families received information about the study prior to participation and provided written informed consent before enrolment.
